Related Experiment Video

Updated: May 20, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Gallium-containing anticancer compounds

Christopher R Chitambar1

  • 1Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI 53226, USA. cchitamb@mcw.edu

Future Medicinal Chemistry
|July 18, 2012
PubMed

Insights

Gallium nitrate shows promise as an anti-cancer drug by inhibiting tumor cell growth and can be used when other treatments fail. Newer gallium compounds are being developed for broader cancer treatment applications.

Area of Science:

  • Oncology
  • Medical Chemistry
  • Pharmacology

Background:

  • There is a critical need for novel cancer therapeutics.
  • Gallium nitrate, a metal salt, demonstrates anti-tumor activity in preclinical and clinical studies.
  • Its mechanism involves iron mimicry, disrupting tumor cell proliferation.

Purpose of the Study:

  • To review the development of gallium compounds for cancer treatment.
  • To discuss the mechanisms of action of gallium-based anti-cancer agents.
  • To highlight the potential of novel gallium compounds in oncology.

Main Methods:

  • Review of existing preclinical and clinical data on gallium nitrate.
  • Analysis of gallium's role as an iron mimetic in cancer cells.
  • Discussion of ongoing research and development of next-generation gallium compounds.

Main Results:

  • Gallium nitrate inhibits tumor cell proliferation in vitro and in vivo.
  • Clinical trials show activity against non-Hodgkin's lymphoma and bladder cancer.
  • Gallium nitrate exhibits no cross-resistance with conventional chemotherapy and is not myelosuppressive.

Conclusions:

  • Gallium compounds represent a promising therapeutic strategy for cancer treatment.
  • Their unique mechanism of action and favorable toxicity profile offer advantages.
  • Further development of gallium-based drugs holds potential for treating a wider range of cancers.

More Related Videos

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue11:22

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...